Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(593/week)
Manufacturing
(401/week)
Energy
(303/week)
Technology
(414/week)
Environment
(248/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Stockholm
Dec 20, 2019
Statement by the Board of Directors of Opus in Relation to the Increased Offer From Ograi, and Update on Current Trading
Dec 18, 2019
Investigator-initiated Phase II Clinical Study of Remetinostat Started in Patients With Squamous Cell Carcinoma
Dec 16, 2019
2019 Study on Sweden's Advanced Facilities - Between Now and 2030, the Country Will Spend? 64 Billion on Railways, Roads, and Other Major Projects
Dec 16, 2019
Futility Analysis Performed of the Phase II Combination Study with Birinapant and Keytruda® in Colorectal Cancer Patients
Dec 07, 2019
Oncopeptides Presents Updated Efficacy and Safety Data from Pivotal Phase 2 HORIZON Study in Patients With RRMM at ASH Annual Meeting 2019
Nov 18, 2019
Medivir Reports Last Patient Recruited to the Phase Ia Study of MIV-818 in Liver Cancer Patients and Initial Dose Determined for phase Ib
Nov 18, 2019
InDex Pharmaceuticals Presents at Redeye Life Science Day and Avanza Börsdag November 19, 2019
Nov 15, 2019
Börje Ekholm to Return to Trimble's Board of Directors
Nov 14, 2019
Extraordinary General Meeting in Oncopeptides AB (publ)
Nov 06, 2019
Oncopeptides to Highlight Data From Melflufen Clinical Program in Multiple Myeloma and AL Amyloidosis in Six Presentations at ASH Annual Meeting 2019
Nov 06, 2019
Alligator Bioscience: ATOR-1017 Induces Long-Lasting Immunity - New Preclinical Data to be Presented at SITC 34th Annual Meeting
Nov 04, 2019
Calliditas Therapeutics Capital Markets Day Today November 4
Oct 31, 2019
Number of Shares and Votes in Oncopeptides
Oct 10, 2019
US National Cancer Institute Initiates Phase I Study of Treatment of Head and Neck Cancer Patients With Medivir's Birinapant and Radiation Therapy
Oct 04, 2019
Invitation to Press and Analyst Conference in Stockholm
Sep 26, 2019
Patient Recruitment in the Pivotal Phase 2-Study HORIZON Completed
Sep 24, 2019
Exercise of Options and Sale of Shares Under the Employee Stock Option Program 2012/2019
Sep 18, 2019
Enea Announces Qosmos Probe 2.1 for Cybersecurity
Sep 15, 2019
New Interim Data in RRMM Patients With Extramedullary Disease from the Pivotal Phase 2 Horizon-study Presented at International Myeloma Workshop
Aug 27, 2019
InDex Pharmaceuticals Meets Primary Endpoint in the Phase IIb Study CONDUCT with Cobitolimod in Ulcerative Colitis
‹‹
Page 3
››
Latest News
Apr 24, 2024
Suzano Ventures invests up to US$5 million into Bioform Technologies to further develop bio-based plastic...
Apr 24, 2024
Woodside Energy Group Ltd Annual General Meeting Address by Chair Richard Goyder and CEO Meg O'Neill
Apr 24, 2024
Rocket Lab Successfully Deploys Satellites ~500km Apart to Separate Orbits For KAIST and NASA
Apr 24, 2024
Sturm, Ruger & Company, Inc. to Report First Quarter 2024 Financial Results on Tuesday, May 7
Apr 24, 2024
Encore Wire Reports First Quarter Results
Apr 24, 2024
UK's Sunak to discuss European security with Scholz in Berlin
Apr 24, 2024
Boeing to give $425 mn advance payments to subcontractor Spirit
Apr 24, 2024
Zelensky remercie le Sénat américain pour le vote de l'aide à l'Ukraine
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events